Safeguarding adults in care homes
Everything NICE has said on safeguarding adults in care homes in an interactive flowchart.
Search results
1202 results
-
-
Rheumatoid arthritis
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
-
Endocrine, nutritional and metabolic conditions
Everything NICE has said on endocrine, nutritional and metabolic conditions in an interactive flowchart
-
Chronic heart failure
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
-
Non-Hodgkin's lymphoma
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
-
Ear, nose and throat conditions
Everything NICE has said on ear, nose and throat conditions in an interactive flowchart
-
Faecal incontinence
Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart
-
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...
-
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12 months) is 140/90 mmHg or less
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12...
-
Bladder cancer
Everything NICE has said on bladder cancer in adults in an interactive flowchart
-
Atrial fibrillation
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
-
Ovarian cancer
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
-
Service user experience in adult mental health services
Everything NICE has said on improving the experience of care for people using adult NHS mental health services in an interactive flowchart
-
Transition between community or care home and inpatient mental health settings
Everything NICE has said on transition between community or care home and inpatient mental health settings in an interactive flowchart
-
Common mental health disorders in primary care
Everything NICE has said on identifying and managing common mental health disorders in adults in primary care in an interactive flowchart
-
Preterm labour and birth
Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart
-
Sarcoma
Everything NICE has said on sarcoma in an interactive flowchart
-
Stroke
Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart
-
Neuropathic pain
Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart
-
Lower limb peripheral arterial disease
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
-
Low back pain and sciatica
Everything NICE has said on low back pain and sciatica in an interactive flowchart
-
Physical activity
Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart
-
Obesity
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
-
Age-related macular degeneration
Everything NICE has said on age-related macular degeneration in an interactive flowchart
-
Asthma
Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart
-
Prevention and control of healthcare-associated infections
Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
-
Caesarean section
Everything NICE has said on caesarean section in an interactive flowchart
-
Suspected cancer recognition and referral
Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart
-
Brain tumours and metastases
Everything NICE has said on brain tumours in adults, including cancer, in an interactive flowchart
-
Cervical cancer
Everything NICE has said on screening and managing cervical cancer in an interactive flowchart
-
Lung cancer
Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart
-
Oesophageal and gastric cancer
Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults
-
Skin conditions
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
-
Dyspepsia and gastro-oesophageal reflux disease
Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
-
Abortion care (QS199)
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
-
Abortion care
Everything NICE has said on abortion care in an interactive flowchart.
-
Venous thromboembolism in adults: diagnosis and management (QS29)
This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.
-
What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have been discharged after treatment for COVID-19 pneumonia?
Recommendation ID NG186/2 Question What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have
-
In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring?
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring
-
In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring intermittent capillary blood glucose monitoring?
Recommendation ID NG3/6 Question In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of
-
What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?
Recommendation ID CG147/6 Question What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people
-
What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial disease and the impact on mortality, morbidity and limb amputation in people with diabetes?
Recommendation ID CG147/7 Question What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial
-
In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid (0.9% sodium chloride vs PlasmaLyte 148) for managing DKA?
Recommendation ID NG18/6 Question In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid
-
What are the most clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Do any symptoms of post‑COVID‑19 syndrome predict the need for specialist intervention? Are there clusters of symptoms that identify response to interventions in post‑COVID‑19 syndrome? What is the clinical effectiveness of different service models of multimodality/multidisciplinary post‑COVID‑19 syndrome rehabilitation in improving patient‑reported outcomes (such as quality of life)? What is the clinical effectiveness of exercise interventions for people with post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Does early exercise rehabilitation assist in improving symptoms of post‑COVID‑19 syndrome?
Recommendation ID NG188/2 Question What are the most clinically effective interventions (including social prescribing and structured community
-
What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over with an acute coronary syndrome, who are having percutaneous coronary intervention (PCI)?
Recommendation ID NG185/1 Question What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over
-
Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus
-
Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate
-
What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
Recommendation ID NG59/8 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
-
Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit. Find out what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG684/1 Question Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent
-
What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19 syndrome present with?
Recommendation ID NG188/5 Question What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19